Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Chongkundang Holdings Corp (001630:KRX), powered by AI.
Chongkundang Holdings Corp is currently trading at ₩41,200. View real-time AI analysis on Alpha Lenz.
View the latest insider trading data for Chongkundang Holdings Corp on Alpha Lenz.
Chongkundang Holdings Corp's P/E ratio is 5.1.
“Chongkundang Holdings Corp trades at a P/E of 5.1 (undervalued) with modest ROE of 6.6%.”
Ask for details →Chongkundang Holdings Corp is a prominent holding company based in South Korea. Its primary function is to manage and oversee its various subsidiary companies, which operate predominantly in the pharmaceutical and health-related sectors. As a holding entity, Chongkundang Holdings Corp provides strategic guidance and financial oversight to its subsidiaries, facilitating operational efficiency and growth. The company's influence extends into diverse industries, often focusing on innovative healthcare solutions, manufacturing of pharmaceuticals, and distribution of medical supplies. This wide-ranging involvement makes Chongkundang Holdings Corp significant in the South Korean financial market, as it aligns with the growing global demand for medical and healthcare advancements. Its role as a holding company positions it as a cornerstone for fostering innovation within its subsidiaries, at the same time impacting broader industry standards and practices.
“Chongkundang Holdings Corp trades at a P/E of 5.1 (undervalued) with modest ROE of 6.6%.”
Ask for details →Chongkundang Holdings Corp (ticker: 001630) is a company listed on KRX in the Healthcare sector (Drug Manufacturers - Specialty & Generic). It has approximately 37 employees. Market cap is $206.4B.
The current price is ₩41,200 with a P/E ratio of 5.11x and P/B of 0.32x.
ROE is 6.60% and operating margin is 6.08%. Annual revenue is $959.0B.